Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 9, 2018

View Archived Issues

Plugging leaks in engineered vasculature

Activin signaling underscores resistance to platinum-based chemotherapy in lung adenocarcinoma

The exerkine apelin reverses age-associated sarcopenia

First participant enrolled in phase III study of M-001 universal flu vaccine candidate

Immunose FLU nasal influenza vaccine candidate demonstrates good safety in older adults

Phase III study of Estelle oral contraceptive meets primary efficacy endpoint

Bayer patents MKNK1 inhibitors

Researchers present new NR1I2 agonists

Medshine Discovery synthesizes WEE1hu inhibitors

Description of a phase I study evaluating locoregional immunotherapy for ovarian cancer recurrence

Positive data announced from phase II extension study of MVA-BN RSV universal vaccine

FDA approves Poteligeo for two subtypes of cutaneous T-cell lymphoma

Identification of genetic prognosticators in glioblastoma survivors by NGS

Positive topline data presented from the pivotal phase III SONICS study of Recorlev

Ambys and Takeda to pioneer first-in-class therapies for the treatment of serious liver diseases

CBT Pharmaceuticals obtains ethics approval in Australia for APOLLO-1 study

Sangamo reports positive preliminary data from Alta study of gene therapy for hemophilia A

Phase I study of EGFR CAR T-cell immunotherapy opens

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...